EMS design and manufacture innovative and cost–effective power monitoring systems for the electricity supply industry from Generation plants to Transmission and Distribution networks.
CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to improve the lives of patients with cancer and inflammatory diseases.
ProAxsis specialises in the development and commercialisation of in vitro diagnostic laboratory assays and point–of–care tests designed to measure active protease biomarkers of disease.